Pulse Biosciences (NASDAQ:PLSE – Get Free Report) will be posting its quarterly earnings results after the market closes on Wednesday, October 30th. Investors that wish to listen to the company’s conference call can do so using this link.
Pulse Biosciences Stock Performance
Shares of Pulse Biosciences stock opened at $17.63 on Wednesday. The stock has a 50 day moving average price of $17.93 and a 200-day moving average price of $13.84. The stock has a market cap of $1.08 billion, a price-to-earnings ratio of -21.77 and a beta of 1.74. Pulse Biosciences has a one year low of $3.78 and a one year high of $22.69.
Analyst Upgrades and Downgrades
Separately, StockNews.com raised shares of Pulse Biosciences to a “sell” rating in a research note on Friday, September 20th.
About Pulse Biosciences
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Featured Articles
- Five stocks we like better than Pulse Biosciences
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- What Are the FAANG Stocks and Are They Good Investments?
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- How to Calculate Stock Profit
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
